| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 572923-05-8 | (4S)-3-(4-Methylphenyl)-4-Phenyl-1,3-Oxazolidin-2-One | C16H15NO2 |
| 572923-06-9 | (4S)-4-Ethyl-3-(4-Methylphenyl)-2-Oxazolidinone | C12H15NO2 |
| 572923-07-0 | (4S)-4-Ethyl-3-(4-Methoxyphenyl)-1,3-Oxazolidin-2-One | C12H15NO3 |
| 572923-10-5 | 4-[(4S)-4-Ethyl-2-Oxo-1,3-Oxazolidin-3-Yl]Benzonitrile | C12H12N2O2 |
| 572923-12-7 | (4S)-4-Ethyl-3-(4-Nitrophenyl)-1,3-Oxazolidin-2-One | C11H12N2O4 |
| 572923-13-8 | Methyl 4-[(4S)-4-Ethyl-2-Oxo-1,3-Oxazolidin-3-Yl]Benzoate | C13H15NO4 |
| 572923-14-9 | (4S)-3-(3-Acetylphenyl)-4-Ethyl-1,3-Oxazolidin-2-One | C13H15NO3 |
| 572923-15-0 | 2-[(4S)-4-Ethyl-2-Oxo-1,3-Oxazolidin-3-Yl]Benzonitrile | C12H12N2O2 |
| 572923-16-1 | 4-[(4S)-4-Ethyl-2-Oxo-1,3-Oxazolidin-3-Yl]-N-Propylbenzamide | C15H20N2O3 |
| 572923-17-2 | (S)-4-(2-Oxo-4-Phenyloxazolidin-3-Yl)-N-Propylbenzamide | C19H20N2O3 |
| 572923-18-3 | (4S)-3-(4-Acetylphenyl)-4-Ethyl-1,3-Oxazolidin-2-One | C13H15NO3 |
| 572923-19-4 | (4S)-3-(4-Acetylphenyl)-4-(1-Methylethyl)-2-Oxazolidinone | C14H17NO3 |
| 572923-21-8 | (4S)-3-(4-Acetylphenyl)-4-Phenyl-1,3-Oxazolidin-2-One | C17H15NO3 |
| 572923-22-9 | (2S)-2-[[4-(Trifluoromethyl)Phenyl]Amino]-1-Propanol | |
| 572923-24-1 | 4-{[(2S)-1-Hydroxy-2-Butanyl]Amino}Benzaldehyde | C11H15NO2 |
| 572923-25-2 | 4-{[(1S)-2-Hydroxy-1-Phenylethyl]Amino}Benzaldehyde | C15H15NO2 |
| 572923-26-3 | (betaS)-beta-[(4-Methylphenyl)Amino]-Benzeneethanol | C15H17NO |
| 572923-27-4 | (2S)-2-[(4-Methylphenyl)Amino]-1-Butanol | C11H17NO |
| 572923-28-5 | (2S)-2-[(4-Methoxyphenyl)Amino]-1-Butanol | C11H17NO2 |
| 572923-29-6 | 4-{[(2S)-1-Hydroxy-2-Butanyl]Amino}Benzonitrile | C11H14N2O |
| 572923-31-0 | (2S)-2-[(4-Nitrophenyl)Amino]-1-Butanol | C10H14N2O3 |
| 572923-32-1 | 1-(4-{[(2S)-1-Hydroxy-2-Butanyl]Amino}Phenyl)Ethanone | C12H17NO2 |
| 572924-00-6 | (S)-2-Cyclopentyloxycarbonylamino-3,3-Dimethyl-Butyric Acid | |
| 572924-54-0 | Deforolimus | C53H84NO14P |
| 573664-50-3 | Anti-Thomsen-Friedenreich Carcinoma Antigen Peptide P30-1 | |
| 573671-91-7 | Bombinakinin-Gap | C145H219N39O39S3 |
| 573673-43-5 | Sorafenib Carboxylic Acid Methyl Ester | C21H15ClF3N3O4 |
| 573674-19-8 | 1-Naphthalenecarboxylic Acid, 4-Hydroxyphenyl Ester | C17H12O3 |
| 573675-25-9 | 5-Bromo-3-nitropyridine-2-carbonitrile | C6H2BrN3O2 |
| 573675-27-1 | 3-Amino-5-bromopyridine-2-carbonitrile | C6H4BrN3 |
| 573675-31-7 | 7-Bromo-4-Chloropyrido[3,2-d]Pyrimidine | C7H3BrClN3 |
| 573675-39-5 | 5-Bromo-3-Hydroxyisoindolin-1-One | |
| 573675-55-5 | 7-Bromo-4-chloroquinazoline | C8H4BrClN2 |
| 573675-60-2 | 3-Fluoro-2-(tributylstannyl)pyridine | C17H30FNSn |
| 573675-91-9 | 2-Methyl-7-[3-(Trifluoromethyl)-2-Pyridinyl]-4(1H)-Quinazolinone | C15H10F3N3O |
| 573676-13-8 | 2-(Isopropylsulfanyl)-5-Nitropyridine | C8H10N2O2S |
| 573676-17-2 | 6-Isopropylsulfonylpyridin-3-Amine | C8H12N2O2S |
| 573681-17-1 | 7-Bromo-2-(Chloromethyl)-4(1H)-Quinazolinone | C9H6BrClN2O |
| 573681-19-3 | 7-Bromo-4-Chloro-2-(Chloromethyl) Quinazoline | |
| 573691-04-0 | 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinethione | C23H27Cl2N3OS |
| 573691-09-5 | 7-[4-[4-(2,3-Dichlorophenyl)-1-oxido-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone | C23H27Cl2N3O3 |
| 573691-11-9 | Aripiprazole N4-Oxide | C23H27Cl2N3O3 |
| 573691-13-1 | Aripiprazole N,N-Dioxide | C23H27Cl2N3O4 |
| 573692-38-3 | 1,2,3,4-Tetrahydro-6-Methyl-2-Oxo-5-Quinoxalinecarbonitrile | |
| 573697-30-0 | 2-Amino-6-Methyl-5-Propyl-4-(1H-Pyrrol-2-Yl)-3-Pyridinecarbonitrile | C14H16N4 |
| 573700-49-9 | 1-[(1E)-1,3-Butadien-1-Yl]-2,5-Pyrrolidinedione | C8H9NO2 |
| 573703-57-8 | (2R,3R)-3-(2-Hydroxyethyl)-2-[(2Z)-2-Penten-1-Yl]Cyclopentanol | C12H22O2 |
| 573704-66-2 | (1R,3R)-rel-1,3-Cyclopentanediamine | C5H12N2 |
| 573711-38-3 | 3-(4-Bromo-1-Methyl-1H-Pyrazol-5-Yl)Aniline | C10H10BrN3 |
| 573711-98-5 | 1-Methyl-5-(3-nitrophenyl)-1H-pyrazole | C10H9N3O2 |